Science
Sniffing Out the Link Between Odor and Disease
Publication: Nautilus
Author: Marta Zaraska
Source published: 17/11/2026, 15:00:00 UTC
Briefing created: 17/11/2026, 16:07:32 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 17/11/2026, 15:08:26 UTC.
Briefings
A 2026 article from Nautilus proposes that specific molecules in breath, skin, and urine can serve as biomarkers for conditions like Parkinson's and cancer. The article suggests scientists could develop non-invasive diagnostic tests based on these biological signatures, though the source does not provide specific chemical names, patient numbers, or clinical trial results.
Key points
- Scientists aim to use volatile molecules from breath, skin, and urine to create non-invasive medical tests for diseases such as Parkinson's and cancer.
- The article is published in 2026 on the Nautilus platform, but no specific chemical compounds, patient counts, or clinical outcomes are detailed in the provided text.
Context
This article explores the potential of using biological signatures from bodily fluids to aid in medical diagnosis, a field that could revolutionize how diseases are monitored without invasive procedures.
Limitations
The evidence provided is a single article from 2026 on Nautilus. It lacks specific chemical names, patient numbers, or clinical trial results. The text does not specify the geographic location of the researchers or the exact nature of the 'clues' mentioned.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 17/11/2026, 16:07:32 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiay6n6d7mybkfozmrnemrfwxedlhapmcah27vajtt5qkerx6cxnwy